Font Size: a A A
Keyword [lung cancer treatment]
Result: 21 - 40 | Page: 2 of 2
21. Clinical Study Of Hua Yin Xiao Pi Plaster Combined With Cisplatin Intrapleural Perfusion Chemotherapy In The Treatment Of Malignant Pleural Effusion Of Lung Cancer Treatment
22. In Vitro Study Of ERBB2 Gene-modified Lentiviral Vector Mediated Dendritic Cells In Lung Cancer Treatment
23. The Theory Of Solid Fixation Guides The Study Of Lung Cancer Treatment
24. The Study Of Ontology Construction And Data Mining Of Professor ZHOU Zhong-ying's Lung Cancer Treatment Knowledge
25. Effect Of Radiotherapy Combined With Element Injection On Advanced Lung Cancer Treatment
26. Research About Lung Cancer Treatment Compatibility Law By Chief Physician Wang Xisheng Based On Hierarchical Latent Structure Model Mining
27. The Research Of Lung Cancer Treatment Based On The Theory Of Fluid
28. Meta-analysis Of The Efficacy And Safety Of PD-1/PD-L1 Inhibitors In The Treatment Of Advanced Non-small Cell Lung Cancer
29. Experiment Research And Dose Evaluation Of 125I Radioactive Seeds Interstitial Brachytherapy In Lung Cancer Treatment
30. Chalcogenide Variation In Organic Conjugated Molecules Based Nanoagents For Non-small Cell Lung Cancer Treatment
31. PD-L1 Nanobody-modified Liposomes For Codelivery Of Gefitinib And Simvastatin For EGFRT790M-Positive Non-Small Cell Lung Cancer Treatment
32. The Clinical Study Of Endu Combined With Cisplatin In The Treatment Of Lung Cancer-related Malignant Pleural Effusion
33. Utilizing positron emission tomography information in lung cancer treatment
34. Inhalable nanoparticles in lung cancer treatment; efficacy, safety, distribution and nanoparticle-macrophage interactions
35. Gender Differences in Lung Cancer Treatment and Survival
36. Taxane conjugate nanoparticles for improved non-small cell lung cancer treatment in a novel orthotopic mouse model
37. Effects Of Histological Heterogeneity And Immune Microenvironment Characteristics On Clinical Treatment And Prognosis Of Small Cell Lung Cancer
38. A Recombinant Oncolytic Adenovirus Expressing A Mutant Soluble Interleukin-6 Receptor In Lung Cancer Treatment
39. Construction Of Nanoprecursor Drug Delivery System Modified By Cell Transmembrane Peptide And Its Application In Lung Cancer Treatment
40. Risk Factors Of Interstitial Lung Disease Induced By Treatment Of Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to